Department of Neurodegenerative Science
68 results.
Earlier this week, The Lancet published results of a phase 3 clinical trial that explored whether the Type 2 diabetes medication exenatide could…
GRAND RAPIDS, Mich. (Jan. 29, 2025) — Van Andel Institute has recruited Bang-An Wang, Ph.D., a neuroscientist who studies brain development and the roots of progressive neurological…
GRAND RAPIDS, Mich. (Jan. 16, 2025) — Van Andel Institute’s free Public Lecture Series returns Feb. 5. This year’s lineup will cover topics such as brain cells,…
GRAND RAPIDS, Mich. (Dec. 20, 2024) — Van Andel Institute has appointed leading Parkinson’s scientist Darren Moore, Ph.D., as the Jay Van Andel Endowed Chair in…
The past year at Van Andel Institute can be summed up in two words: “growth” and “impact.”
We’ve expanded our research capacity by adding new…
In September, Van Andel Institute welcomed nearly 300 scientists, physicians and people with Parkinson’s for our annual Grand Challenges in Parkinson’s Disease symposium and Rallying…
Depression is a common mental health disorder, and its emotional and psychological symptoms are well known. Perhaps less known are the various biological factors that…
Grand Rapids, Mich. (Sept. 25, 2024) — Cure Parkinson’s and Van Andel Institute (VAI) are delighted to announce